Adjuvant immunotherapy with nivolumab versus observation in completely resected Merkel cell carcinoma (ADMEC-O): disease-free survival results from a randomised, open-label, phase 2 trialJürgen C. Becker, Lucie Heinzerling, Felix Kiecker et al.|The Lancet|2023Cited by 75
Electrochemotherapy in advanced skin tumors and cutaneous metastases – a retrospective multicenter analysisAlexander Kreuter, Kerstin Lommel, Tina van Eijk et al.|JDDG Journal der Deutschen Dermatologischen Gesellschaft|2015Cited by 44
Improved survival of advanced melanoma patients receiving immunotherapy with concomitant antithrombotic therapy – A multicenter study on 2419 patients from the prospective skin cancer registry ADORegJulian Kött, N. Devereux, Tim Zell et al.|European Journal of Cancer|2024Cited by 16
Treatment at the end of life in patients with advanced melanoma. A multicenter DeCOG study of 1067 patients from the prospective skin cancer registry ADORegAndrea Forschner, Carmen Loquai, Katharina C. Kähler et al.|Frontiers in Immunology|2025Cited by 4
Elektrochemotherapie bei fortgeschrittenen Hauttumoren und Hautmetastasen – eine retrospektive multizentrische AuswertungAlexander Kreuter, Kerstin Lommel, Tina van Eijk et al.|JDDG Journal der Deutschen Dermatologischen Gesellschaft|2015Cited by 3